PulseSight plans to submit a phase I clinical trial authorization (CTA) by the end the year, to be closely followed by a phase II proof-of-concept to demonstrate the efficacy and the safety of its ...
As a proud member of the Women’s Gift Alliance for 20 years, I am here to tell you that philanthropy does ... Through the years, WGA has funded programs providing services to infants, foster kids, the ...